N. Mhlongo

Drug Design, Development and Therapy · 2017

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom N. Mhlongo trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. T. Seyfried

Papers from N. Mhlongo's perspective

Ordered by how strongly the researchers N. Mhlongo trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The status of platinum anticancer drugs in the clinic and in clinical trials. (Dalton Transactions)
  2. ‘New Trends for Metal Complexes with Anticancer Activity’ (Current Opinion in Chemical Biology)
  3. Cancer as a metabolic disease (Nutrition and Metabolism)
  4. Mitochondrial signaling: the retrograde response. (Molecules and Cells)
  5. An Integrated Genomic Analysis of Human Glioblastoma Multiforme (Science)
  6. The hallmarks of cancer (RNA Biology)
  7. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? (Nature reviews. Drug discovery)
  8. The metastatic niche: adapting the foreign soil (Nature Reviews. Cancer)
  9. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. (Journal of Clinical Investigation)
  10. A mutator phenotype in cancer. (Cancer Research)

Their papers